Director of Clinical & Scientific Affairs, Genetic Technologies (GT)
Erika Spaeth is responsible for the development of GT's clinical content and clinical rationale for GTG products. She has wide experience in the high complexity laboratory space from assay development to regulatory oversight of laboratory developed tests in oncology, infectious disease, and inherited disease. Her postdoctoral training was completed at MD Anderson Cancer Center where she focused on the role of the microenvironment in tumor progression.
Chief Commercial Officer, GT
Carl Stubbings has considerable experience commercializing diagnostic products, both locally and globally. More recently, he has assisted multiple Australian biotech companies with their commercialization strategies. Stubbings has a Bachelor of Applied Science degree in medical technology from the Queensland University of Technology.
Solution Science Director, DNAnexus
John Penn is an expert in the cloud-based computational analysis of genomic data. He has spent over 20 years in bioinformatics in expanding roles in academic medical research, clinical diagnostics, pharma, and extensive work at the Regeneron Genetics Center, where he achieved success through greater efficiency, flexibility and market reach using cloud technology.
SVP, Global Marketing, DNAnexus
Sam Stein leads marketing at DNAnexus and is responsible for all aspects of the company’s marketing strategy and execution. Stein brings a wealth of experience defining go-to-market strategies in enterprise software, with a specific focus on life sciences and healthcare IT. He holds an MBA from UCLA’s Anderson School of Management and a bachelor’s degree from Vanderbilt University.
